Genotype determines phenotype in experimental lyme borreliosis

Annals of Neurology

Volumn 56, Issue 3, 2004, Pages 361-370

  Pachner, Andrew R ^a   Dail, Donna ^a   Bai, Yunhong ^a   Sondey, Marie ^a   Pak, Lena ^a   Narayan, Kavitha ^a   Cadavid, Diego ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA BURGDORFERI SENSU LATO; BORRELIA BURGDORFERI SENSU STRICTO; BORRELIA GARINII; BRAIN INFECTION; CONTROLLED STUDY; EUROPE; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; GENOTYPE; IMMUNE RESPONSE; INFLAMMATION; ISOLATION PROCEDURE; LYME DISEASE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN INFECTION; SPECIES DIFFERENTIATION; SPIROCHETE; SURVIVAL; WESTERN HEMISPHERE;

ANIMALS; BORRELIA BURGDORFERI; BORRELIA BURGDORFERI GROUP; DISEASE MODELS, ANIMAL; GENOTYPE; HUMANS; LYME DISEASE; MACACA MULATTA; MALE; MICE; MICE, INBRED C3H; PHENOTYPE;

EID: 4444374059     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20192     Document Type: Article

References (73)

1. Stanek G, Pletschette M, Flamm H, et al. European Lyme borreliosis. Ann NY Acad Sci 1988;539:274-282.
2. Liveris D, Gazumyan A, Schwartz I. Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 1995;33:589-595.
3. Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 1999;12: 633-653.
4. Busch U, Hizo-Teufel C, Boehmer R, et al. Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR. J Clin Microbiol 1996;34:1072-1078.
5. Marconi RT, Hohenberger S, Jauris-Heipke S, et al. Genetic analysis of Borrelia garinii OspA serotype 4 strains associated with neuroborreliosis: evidence for extensive genetic homogeneity. J Clin Microbiol 1999;37:3965-3970.
6. Lebech AM, Hansen K, Wilske B, Theisen M. Taxonomic classification of 29 Borrelia burgdorferi strains isolated from patients with Lyme borreliosis: a comparison of five different phenotypic and genotypic typing schemes. Med Microbiol Immunol (Berl) 1994;183:325-341.
7. Wormser GP, Liveris D, Nowakowski J, et al. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis 1999;180: 720-725.
8. Wilske B, Schierz G, Preac-Mursic V, et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis 1986;153:304-314.
9. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992;115:399-423.
10. Asbrink E, Hovmark A, Olsson I. Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986;263:253-261.
11. Kristoferitsch W, Sluga E, Graf M, et al. Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features. Ann NY Acad Sci 1988;539:35-45.
12. Dhote R, Basse-Guerineau AL, Beaumesnil V, et al. Full spectrum of clinical, serological, and epidemiological features of complicated forms of Lyme borreliosis in the Paris, France, area. Eur J Clin Microbiol Infect Dis 2000;19:809-815.
13. Steere AC, Berardi VP, Weeks KE, et al. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 1990;161:1203-1209.
14. Stiernstedt G, Gustafsson R, Karlsson M, et al. Clinical manifestations and diagnosis of neuroborreliosis. Ann NY Acad Sci 1988;539:46-55.
15. Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 1985;35:47-53.
16. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med 1998;339: 216-222. Published erratum appears in N Engl J Med 1998; 339:571.
17. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med 1998;339: 216-222. Published erratum appears in N Engl J Med 1998; 339:571.
18. Dekonenko EJ, Steere AC, Berardi VP, Kravchuk LN. Lyme borreliosis in the Soviet Union: a cooperative US-USSR report. J Infect Dis 1988;158:748-753.
19. Steere A, Schoen R, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987;107:725-731.
20. Hansen K. Lyme neuroborreliosis: improvements of the laboratory diagnosis and a survey of epidemiological and clinical features in Denmark 1985-1990. Acta Neurol Scand Suppl 1994; 151:1-44.
21. Barthold SW, Moody KD, Terwilliger GA, et al. An animal model for Lyme arthritis. Ann NY Acad Sci 1988;539: 264-273.
22. Pachner AR, Itano A. Borrelia burgdorferi infection of the brain: characterization of the organism and response to antibiotics and immune sera in the mouse model. Neurology 1990;40: 1535-1540.
23. Pachner AR, Delaney E, O'Neill T, Major E. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology 1995;45:165-172.
24. Pachner AR, Zhang WF, Schaefer H, et al. Detection of active infection in nonhuman primates with Lyme neuroborreliosis: comparison of PCR, culture, and a bioassay. J Clin Microbiol 1998;36:3243-3247.
25. Pachner AR, Ricalton N, Delaney E. Comparison of polymerase chain reaction with culture and serology for diagnosis of murine experimental Lyme borreliosis. J Clin Microbiol 1993; 31:208-214.
26. Pachner AR, Basta J, Delaney E, Hulinska D. Localization of Borrelia burgdorferi in murine Lyme borreliosis by electron microscopy. Am J Trop Med Hyg 1995;52:128-133.
27. Pachner AR, Delaney E, Ricalton NS. Murine Lyme borreliosis: route of inoculation determines immune response and infectivity. Reg Immunol 1992;4:345-351.
28. Pachner AR, Schaefer H, Amemiya K, et al. Pathogenesis of neuroborreliosis-lessons from a monkey model. Wien Klin Wochenschr 1998;110:870-873.
29. Pachner AR, Amemiya K, Bartlett M, et al. Lyme Borreliosis in Rhesus Macaques: effects of corticosteroids on spirochetal load and isotype switching of anti-Borrelia burgdorferi antibody. Clin Diagn Lab Immunol 2001;8:225-232.
30. Pachner AR, Cadavid D, Shu G, et al. Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis. Ann Neurol 2001;50: 330-338.
31. Pachner AR, Dail D, Li L, et al. Humoral immune response associated with lyme borreliosis in nonhuman primates: analysis by immunoblotting and enzyme-linked immunosorbent assay with sonicates or recombinant proteins. Clin Diagn Lab Immunol 2002;9:1348-1355.
32. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983;308:733-740.
33. Cox DL, Akins DR, Bourell KW, et al. Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins. Proc Natl Acad Sci USA 1996;93:7973-7978.
34. Akins DR, Porcella SF, Popova TG, et al. Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. Mol Microbiol 1995;18: 507-520.
35. Wilske B, Barbour AG, Bergstrom S, et al. Antigenic variation and strain heterogeneity in Borrelia spp. Res Microbiol 1992; 143:583-596.
36. Barbour AG, Maupin GO, Teltow GJ, et al. Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness. J Infect Dis 1996;173:403-409.
37. Cadavid D, Bai Y, Dail D, et al. Infection and inflammation in skeletal muscle from non-human primates infected with different genospecies of the Lyme disease spirochete Borrelia burgdorferi. Infect Immun 2003;71:7087-7098.
38. Cadavid D, O'Neill T, Schaefer H, Pachner AR. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease. Lab Invest 2000;80:1043-1054.
39. Pachner AR, Ricalton NS. Western blotting in evaluating Lyme seropositivity and the utility of a gel densitometric approach. Neurology 1992;42:2185-2192.
40. Bai Y, Narayan K, Dail D, et al. Spinal cord involvement in the non-human primate model of Lyme disease. Lab Invest 2004; 84:160-172.
41. Barthold SW, deSouza MS, Janotka JL, et al. Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol 1993;143: 959-972.
42. Schaible UE, Gay S, Museteanu C, et al. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am J Pathol 1990; 137:811-820.
43. Gern L, Schaible UE, Simon MM. Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J Infect Dis 1993; 167:971-975.
44. Barthold SW, de Souza MS, Janotka JL, et al. Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol 1993;143: 959-971.
45. Armstrong AL, Barthold SW, Persing DH, Beck DS. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg 1992;47:249-258.
46. Barthold SW, Persing DH, Armstrong AL, Peeples RA. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol 1991;139: 263-273.
47. Masuzawa T, Beppu Y, Kawabata H, et al. Experimental Borrelia burgdorferi infection of outbred mice. J Clin Microbiol 1992;30:3016-3018
48. Goodman JL, Jurkovich P, Kodner C, Johnson RC. Persistent cardiac and urinary tract infections with Borrelia burgdorferi in experimentally infected Syrian hamsters. J Clin Microbiol 1991; 29:894-896.
49. Lawrenz MB, Wooten RM, Zachary JF, et al. Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun 2003;71:4432-4440.
50. Barthold SW. Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato species. Infect Immun 1999;67: 36-42.
51. Tuomi J, Rantamaki LK, Tanskanen R. Experimental infection of cattle with several Borrelia burgdorferi sensu lato strains; immunological heterogeneity of strains as revealed in serological tests. Vet Microbiol 1998;60:27-43.
52. Tuomi J, Rantamaki LK, Tanskanen R. Experimental infection of laboratory mice and rabbits with several isolates of Borrelia burgdorferi sensu lato; comparison of antigens from different genospecies in serological measurement of immune responses. Comp Immunol Microbiol Infect Dis 2002;25:109-125.
53. Gern L, Hu CM, Voet P, et al. Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii. Vaccine 1997;15:1551-1557.
54. Oteo JA, Backenson PB, del Mar Vitutia M, et al. Use of the C3H/He Lyme disease mouse model for the recovery of a Spanish isolate of Borrelia garinii from erythema migrans lesions. Res Microbiol 1998;149:39-46.
55. Escudero R, Barral M, Perez A, et al. Molecular and pathogenic characterization of Borrelia burgdorferi sensu lato isolates from Spain. J Clin Microbiol 2000;38:4026-4033.
56. Gylfe A, Bergstrom S, Lundstrom J, Olsen B. Reactivation of Borrelia infection in birds. Nature 2000;403:724-725.
57. Ishiguro F, Takada N, Masuzawa T, Fukui T. Prevalence of Lyme disease Borrelia spp. in ticks from migratory birds on the Japanese mainland. Appl Environ Microbiol 2000;66:982-986.
58. Humair PF. Birds and Borrelia. Int J Med Microbiol 2002; 291(suppl 33):70-74.
59. Gray JS, Robertson JN, Key S. Limited role of rodents as reservoirs of Borrelia burgdorferi sensu lato in Ireland. Eur J Epidemiol 2000;16:101-103.
60. Balmelli T, Piffaretti JC. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol 1995;146:329-340.
61. Ohlenbusch A, Matuschka FR, Richter D, et al. Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis 1996;174:421-423.
62. Picken RN, Strle F, Ruzic-Sabljic E, et al. Molecular subtyping of Borrelia burgdorferi sensu lato isolates from five patients with solitary lymphocytoma. J Invest Dermatol 1997;108:92-97.
63. Breitner-Ruddock S, Wurzner R, Schulze J, Brade V. Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi. Med Microbiol Immunol (Berl) 1997;185:253-260.
64. Kraiczy P, Hunfeld KP, Breitner-Ruddock S, et al. Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates. Immunobiology 2000; 201:406-419.
65. McDowell JV, Wolfgang J, Tran E, et al. Comprehensive analysis of the factor h binding capabilities of borrelia species associated with lyme disease: delineation of two distinct classes of factor h binding proteins. Infect Immun 2003;71:3597-3602.
66. Keller TL, Halperin JJ, Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 1992;42:32-42.
67. Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 1990;28:473-479.
68. Pachner AR, Delaney E. The polymerase chain reaction (PCR) in the diagnosis of Lyme neuroborreliosis. Ann Neurol 1993; 34:544-550.
69. Lebech AM, Hansen K. Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction. J Clin Microbiol 1992;30:1646-1653.
70. Malawista SE, Barthold SW, Persing DH. Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J Infect Dis 1994;170:1312-1316.
71. Kindstrand E, Nilsson BY, Hovmark A, et al. Polyneuropathy in late Lyme borreliosis-a clinical, neurophysiological and morphological description. Acta Neurol Scand 2000;101: 47-52.
72. Kindstrand E, Nilsson BY, Hovmark A, et al. Peripheral neuropathy in acrodermatitis chronica atrophicans-effect of treatment. Acta Neurol Scand 2002;106:253-257.
73. van Dam AP. Diversity of Ixodes-borne Borrelia species-clinical, pathogenetic, and diagnostic implications and impact on vaccine development. Vector Borne Zoonotic Dis 2002;2: 249-254.